Randomised controlled trial of fish oil supplement to treat cancer cachexia

Ann Dewey; Bernard Robert Higgins; C Baughan; Rebecca Jane Stores; Taraneh Dean; Sally Anne Kilburn

Randomised controlled trial of fish oil supplement to treat cancer cachexia

Ann Dewey
, Bernard Robert Higgins
, C Baughan
, Rebecca Jane Stores
, Taraneh Dean
, Sally Anne Kilburn

University Hospital Southampton NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

898 Downloads (Pure)

Abstract

Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.

Original language	English
Article number	002
Journal	BAOJ Palliative medicine
Volume	1
Issue number	1
Publication status	Published - 24 Apr 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

Randomised Controlled Trial of Fish OilFinal published version, 831 KBLicence: CC BY

http://bioaccent.org/palliative-medicine/palliative-medicine02.php

Cite this

@article{abe43836f3c7423a8bdefe28ff181754,

title = "Randomised controlled trial of fish oil supplement to treat cancer cachexia",

abstract = "Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.",

author = "Ann Dewey and Higgins, \{Bernard Robert\} and C Baughan and Stores, \{Rebecca Jane\} and Taraneh Dean and Kilburn, \{Sally Anne\}",

year = "2015",

month = apr,

day = "24",

language = "English",

volume = "1",

journal = "BAOJ Palliative medicine",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Randomised controlled trial of fish oil supplement to treat cancer cachexia

AU - Dewey, Ann

AU - Higgins, Bernard Robert

AU - Baughan, C

AU - Stores, Rebecca Jane

AU - Dean, Taraneh

AU - Kilburn, Sally Anne

PY - 2015/4/24

Y1 - 2015/4/24

N2 - Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.

AB - Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing the omega-3 fatty acid eicosapentaenoic acid (EPA) was able to improve quality of life and survival times of patients with advanced solid tumour cancer in a mixed tumour cancer type population.

M3 - Article

VL - 1

JO - BAOJ Palliative medicine

JF - BAOJ Palliative medicine

IS - 1

M1 - 002

ER -

Randomised controlled trial of fish oil supplement to treat cancer cachexia

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this